Malignant Melanoma
4 competing products in clinical development for Malignant Melanoma.
Pipeline by Phase
Phase 1/21
Phase 21
Phase 32
All Products (4)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Pembrolizumab + Lenvatinib + Placebo for lenvatinib | Eisai | Phase 3 | Completed | 40 |
| Pembrolizumab + Lenvatinib + Placebo for lenvatinib | Eisai | Phase 3 | Completed | 40 |
| Decitabine + Temozolomide | Eisai | Phase 1/2 | Completed | 32 |
| CP-461 | Astellas Pharma | Phase 2 | Terminated | 27 |